News | July 22, 2024
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
Natco Pharma intends to defend the matter accordingly
Submission based on results from pivotal phase III trial showing all primary endpoints met
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
The pilot plant is focused on scaling up beverage production and will support applications
Varenicline is indicated for smoking cessation in adults
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
The registered capital of the newly founded company is € 50 million
Subscribe To Our Newsletter & Stay Updated
